Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-19

Clinical Trial Update: 1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in Vietnam comparing 1HP (isoniazid + rifapentine) to 3HR (isoniazid + rifampin) for latent tuberculosis infection; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)
  • RIFAMPIN (RIFAMPIN)
  • rifapentine (rifapentine)

Snippet

Sponsor: Freundeskreis Für Internationale Tuberkulosehilfe e.V | Conditions: Tuberculosis Infection | Phase 3 | Status: NOT_YET_RECRUITING